Michał Gniot
7PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 20, 2022
Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels.Krzysztof Lewandowski, Zuzanna Kanduła, Michał Gniot
|Oct 14, 2022
Molecular Changes in Chronic Myeloid Leukemia During Tyrosine Kinase Inhibitors Treatment. Focus on Immunological Pathways.Michał Janowski, Zofia Ulańczyk, Karolina Łuczkowska
|May 25, 2022
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study.Helen E White, Matthew Salmon, Francesco Albano
|Dec 21, 2021
Validation of HER2 Status in Whole Genome Sequencing Data of Breast Cancers with the Ploidy-Corrected Copy Number Approach.Marzena Wojtaszewska, Rafał Stępień, Alicja Woźna
|Aug 08, 2019
Characterization and significance of the Philadelphia negative/<i>BCR-ABL1</i> positive rearrangement or masked Philadelphia translocation in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single-center study.Blazej Ratajczak, Michal Gniot, Anna Przybylowicz-Chalecka
|Mar 07, 2018
Coexistence of JAK2 or CALR mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.K Lewandowski, M Gniot, M Wojtaszewska
Pageof 2
Frequent Collaborators
3 joint publications
Krzysztof Lewandowski
2 joint publications
Marzena Wojtaszewska
2 joint publications
Edyta Paczkowska
1 joint publications
Tomasz Sacha
1 joint publications
Blazej Ratajczak
1 joint publications
Anna Przybylowicz-Chalecka
1 joint publications
Joanna Czerwinska-Rybak
1 joint publications
Mieczyslaw Komarnicki
1 joint publications
Malgorzata Jarmuz-Szymczak
1 joint publications
Alicja Woźna
